Table 1.
Clinical, pathological, surgical data of 17 children who underwent to ICG guided liver resection/transplantation for HB.
| Pt no. | Age (month/sex) | BWT at surgery | PRETEXT | Tumor diameter (cm) | The number of tumors (CT) | Metastasis | Invasion | AFP (ng/dL) at surgery | Interval time of ICG injection/surgery (h) | ICGPattern | Pathology/Necrosis(%) | Procedure | Safety margin (cm) | Disease-free survival (months) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 4/M | 6.2 | III | 2.4 | 1 | 88 | 26.3 | diffuse | Fetal/ <5 | RAS | 0 | 43 | ||
| 2 | 19/M | 10.5 | IV | 4.7, DN*3 | 4 | Lung | Diaphragm, Rt. adrenal gland | 5,830 | 22.7 | uneven | Epithelial and mesenchymal/95 | PH (S6–8, S2/pS3) | 2 | 41 |
| 3 | 18/F | 9.8 | I/III | 6.3 | 1 | 14,800 | 26.3 | diffuse | Fetal/0 | Laparoscopic LLS | 4 | 38 | ||
| 4 | 13/F | 10 | II | 2.5 | 1 | 30 | 20.5 | diffuse | Epithelial and mesenchymal/ <5 | LLS | 5 | 35 | ||
| 5 | 10/M | 9.4 | III | 3.9 | 1 | MHV | 464 | 27.9 | uneven | Epithelial and mesenchymal/99 | CBS | 0 | 17 | |
| 6 | 140/F | 33.9 | I | 13.2 | 1 | 19,199 | 27.0 | uneven | Fetal and embryonal/10 | LLS | 11 | 12 | ||
| 7 | 43/F | 9.4 | IV | 3.4, DN*6 | 7 | Lung | 791 | 23.2 | diffuse | Fetal/80 | RH | 3 | 8 | |
| 46/F | 10.2 | 4 | 1 | 55.2 | 39.3 | uneven | Fetal and Chemotherapy-associated vasculopathy/unknown | LLS | 0 | |||||
| 8 | 6/M | 7.1 | III | 5.5 | 1 | IVC, PV | 508 | 45.7 | undetected | Fetal/80 | RTS, PH(S1) | 1 | 7 | |
| 9 | 16/M | 9 | III | 5.7, DN*4 | 5 | Lung | Diaphragm | 471 | 37.3 | uneven | Epithelial and mesenchymal/90 | ERH | 0.2 | 7 |
| 10 | 70/F | 14.6 | III | 7, DN*2 | 3 | Lung | Rt. adrenal gland | 2,710 | 41.2 | diffuse | Fetal/40 | ERH, PH(S2) | 4 | |
| 72/F | 15.1 | 0.5, 1.4 | 3 | 16 | 40.3 | diffuse | Fetal/unknown | Segmentectomy (S2, S4) | 0.3 | |||||
| 11 | 5/M | 6.9 | III | 4.8 | 1 | 207 | 40.0 | uneven | Epithelial and mesenchymal/ <5 | CBS | 0 | 5 | ||
| 12 | 15/M | 9.3 | II | 4.6, 4.8 | 2 | 3,060 | 41.2 | undetected | Epithelial and mesenchymal/unknown | CBS | 0.9 | 6 | ||
| 13 | 9/F | 8 | III | 6.1 | 1 | IVC | 70 | 39.9 | diffuse | Epithelial and mesenchymal/0 | RH, S1 | 0 | 5 | |
| 14 | 12/M | 9.6 | III | 4.9 | 1 | 769 | 41.5 | diffuse | Epithelial and mesenchymal/30 | RTS | 0.2 | 2 | ||
| 15 | 71/F | 20.5 | III | 6.2 | 1 | Lung | 13,000 | 42.3 | uneven | Fetal/15 | LH | 2.5 | 2 | |
| 16 | 96/M | 28 | IV | 13.2 | Multi | Diaphragm, RHV/MHV RHV/MHV | 30,500 | 36.7 | uneven | Fetal/7 | LT | none | 10 | |
| 17 | 18/F | 10.1 | IV | 10.5 | Multi | Lung | 237 | 50.3 | uneven | Epithelial and mesenchymal/30 | LT | none | 2 |
ERH, extended right hepatectomy; R(L)H, right(left) hepatectomy; PH, partial hepatectomy; CBS, central bisegmentectomy; R(L)TS, right(left) trisegmentectomy; LTx, liver transplantation; LLS, left lateral segmentectomy; RAS, right anterior segmentectomy; DN, daughter nodule; MHV, middle hepatic vein; IVC, inferior vena cava; PV, portal vein; RHV, right hepatic vein; MHV, middle hepatic vein.